Zai Lab Stock Guidance | NASDAQ:ZLAB

Comments

Zai Lab Ltd Stock Guidance

ZLABNASDAQ

Trade with Public

$20.68

-0.06-0.29%

At close: Apr 10, 5:00 PM EST

$20.56

-0.12-0.58%

After Hours: 4:55 PM EST

Overview News Earnings OptionsGuidanceAnalyst Ratings Insider Trades Short Interest Stock Report

Zai Lab (ZLAB) last issued guidance on November 6, 2025 for fiscal year 2025. The company guided revenue in the range of for the period.

Compared to prior guidance, Zai Lab maintained its revenue forecast from a prior range of $560.00M - $590.00M.

Zai Lab has issued 3 guidance updates between February 27, 2025 and August 7, 2025. This history provides investors with insight into management's expectations over time.

Latest Guidance Date

Nov 6, 2025

Guidance Period

Full Year 2025

Zai Lab Guidance History

Review all historical guidance issued by Zai Lab, including EPS and revenue forecasts across quarterly and annual periods.

Loading calendar...

FAQ

What is the most recent guidance for Zai Lab (ZLAB)?

The most recent guidance for Zai Lab (ZLAB) was reported on August 7, 2025 for the fiscal year 2025. Zai Lab forecasted revenue between $560.00M and $590.00M for the period.

What revenue range did Zai Lab (ZLAB) guide for?

Zai Lab (ZLAB) guided revenue in the range of $560.00M to $590.00M for the fiscal year 2025.

Did Zai Lab (ZLAB) raise or lower guidance?

Zai Lab (ZLAB) maintained its revenue guidance from a prior range of $560.00M - $590.00M to $560.00M - $590.00M for the fiscal year 2025.

When did Zai Lab (ZLAB) last issue guidance?

Zai Lab (ZLAB) last issued guidance on November 6, 2025 for the fiscal year 2025.

People Also Watch

Immunome Inc

NASDAQ:IMNM

$21.67

Ultragenyx Pharmaceutical Inc

NASDAQ:RARE

$23.26

-0.17%

Sarepta Therapeutics Inc

NASDAQ:SRPT

$21.32

0.66%

Ascentage Pharma Group International

NASDAQ:AAPG

$25.50

0.67%

Syndax Pharmaceuticals Inc

NASDAQ:SNDX

$24.44

Day One Biopharmaceuticals Inc